Immediate Impact
2 from Science/Nature 51 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Works of Ruofei Yu being referenced
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors
2022
Significance of tumor‐associated autoantibodies in the early diagnosis of lung cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ruofei Yu | 71 | 114 | 132 | 180 | 9 | 383 | |
| Christopher L. Yankaskas | 44 | 167 | 130 | 140 | 8 | 438 | |
| Hisashi Hagiwara | 13 | 236 | 71 | 74 | 7 | 434 | |
| Min‐Goo Lee | 129 | 231 | 69 | 30 | 12 | 432 | |
| Joshua D. Greenlee | 42 | 199 | 100 | 64 | 12 | 373 | |
| Veronika te Boekhorst | 16 | 128 | 109 | 78 | 7 | 352 | |
| Muhlis Akman | 48 | 191 | 100 | 44 | 14 | 421 | |
| Jihu Dong | 31 | 279 | 212 | 35 | 8 | 445 | |
| Lauriane Cabon | 23 | 262 | 82 | 62 | 14 | 422 | |
| Qiongxi Pan | 12 | 259 | 66 | 61 | 10 | 432 | |
| Keith H. Jansson | 123 | 191 | 141 | 55 | 9 | 363 |
All Works
Login with ORCID to disown or claim papers
Loading papers...